The potential of peptide immunotherapy in allergy and asthma.

被引：8

作者：

Ali F.R. ^{[1
]}

Kay A.B. ^{[1
]}

Larché M. ^{[1
]}

机构：

[1] Department of Allergy and Clinical Immunology, Faculty of Medicine, Imperial College, National Heart and Lung Institute, Dovehouse Street, London

来源：

Current Allergy and Asthma Reports | 2002年 / 2卷 / 2期

基金：

英国医学研究理事会;

关键词：

Major Histocompatibility Complex; Allergy Clin Immunol; Cell Anergy; House Dust Mite Allergen; Late Asthmatic Reaction;

D O I：

10.1007/s11882-002-0010-5

中图分类号：

学科分类号：

摘要：

Allergic conditions contribute significantly to the burden of chronic disease in the industrialized world. Current treatments offer varying degrees of palliation. The sole proven disease-modifying strategy, specific or whole-allergen immunotherapy, is limited because of the associated risk of systemic adverse effects, such as anaphylaxis. Short, linear allergen-derived peptides, corresponding to T cell epitopes, offer the possibility of a safer approach as they are capable of inducing allergen-specific hyporesponsiveness without cross-linking mast cell-bound IgE. This review evaluates the scientific basis of peptide immunotherapy and clinical experience in allergy up to the present time.

引用

页码：151 / 158

页数：7

共 136 条

[21]

Corrigan CJ(1993)Peripheral T-cell tolerance induced in naive and primed mice by subcutaneous injection of peptides from the major cat allergen Fel d 1 Proc Natl Acad Sci U S A 90 7608-7612

[22]

Bentley AM(1993)Inhibition of T-cell and antibody responses to house dust mite allergen by inhalation of the dominant T-cell epitope in naive and sensitised mice J Exp Med 178 1783-1788

[23]

Meng Q(1996)Regulation of house dust mite responses by intranasally administered peptide: transient activation of CD4+ T cells precedes the development of tolerance in vivo Int Immunol 8 335-342

[24]

Robinson DS(2000)Inducing tolerance by intranasal administration of long peptides in naive and primed CBA/J mice J Immunol 165 3497-3505

[25]

Robinson D(1998)Domestic allergens in public places. III. House dust mite, cat, dog, and cockroach allergens in British hospitals Clin Exp Allergy 28 53-59

[26]

Hamid Q(1996)Definition of the human T-cell epitopes of Fel d 1, the major allergen of the domestic cat J Allergy Clin Immunol 98 884-894

[27]

Bentley A(1996)Treatment of cat allergy with T-cell reactive peptides Am J Respir Crit Care Med 154 1623-1628

[28]

Huang SK(1998)Effects of peptide therapy on ex-vivo T-cell responses J Allergy Clin Immunol 101 506-513

[29]

Xiao HQ(1998)Immunotherapy with Fel d 1 peptides decreases IL-4 release by peripheral blood T-cells of patients allergic to cats J Allergy Clin Immunol 102 571-578

[30]

Kleine-Tebbe J(1996)Fel d 1 peptides: effect on skin tests and cytokine synthesis in cat-allergic human subjects Int Immunol 8 1937-1945

← 1 2 3 4 5 6 7 8 9 10 →